Karan S.

Karan S. is an accomplished professional with extensive experience in analytical development and quality control within the biopharmaceutical industry. Currently serving as Director at Dyne Therapeutics since April 2021, Karan has previously held significant roles at Translate Bio and ImmunoGen, Inc., where responsibilities included analytical assay development, formulation development, and regulatory support. Karan has demonstrated expertise in method evaluations, stability testing, comparability testing, and biophysical characterization, contributing to pivotal clinical phase advancements. Karan's academic background includes a Master of Science in Pharmaceutical Sciences from Northeastern University and a Mini-MBA in BioPharma Innovation from Rutgers Business School, complemented by a Bachelor of Pharmacy from The Maharaja Sayajirao University of Baroda.